BROMOCRIPTINE THERAPY IN 3 PATIENTS WITH PROLACTIN SECRETING PITUITARY-ADENOMAS

被引：0

作者：

SAPUNAR, J ^{[1
]}

LOPEZ, JM ^{[1
]}

HUETE, I ^{[1
]}

TAGLE, R ^{[1
]}

机构：

[1] CATHOLIC UNIV CHILE,HOSP CLIN,DEPT RADIOL,SANTIAGO,CHILE

来源：

REVISTA MEDICA DE CHILE | 1992年 / 120卷 / 02期

关键词：

PITUITARY NEOPLASMS; ADENOMA; PROLACTIN; BROMOCRIPTINE; PROGNOSIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bromocriptine was used to treat 3 patients with prolactin secreting pituitary adenoma. Diagnosis was based on the presence of a sellar tumor over 1 cm in size at CT scanning and a serum prolactin concentration above 150 ng/ml. All patients were symptomatic from pituitary hypofunction or from tumor compression of neighboring areas. Bromocriptine was given at increasing doses up to 10 mg/day. Prolactine reached normal levels 1 to 7 months later. Tumor reduction was confirmed by high resolution scanning. The mechanism of bromocriptine effect on these tumors is discussed.

引用

页码：168 / 173

页数：6

共 50 条

[41] DIAGNOSIS OF PITUITARY-ADENOMAS ON TOUCH PREPARATIONS ASSISTED BY IMMUNOCYTOCHEMISTRY
KONTOGEORGOS, G
BASSIOUKA, I
GIANNOU, P
VAMVASSAKIS, E
ROLOGIS, D
ORPHANIDIS, G
ACTA CYTOLOGICA, 1995, 39 (02) : 141 - 152
[42] EFFECT OF THE GABA(A) AGONIST MUSCIMOL ON PROLACTIN SECRETION FROM HUMAN PROLACTIN-SECRETING ADENOMAS AND GH3 RAT PITUITARY-TUMOR CELLS
JONES, TH
BROWN, BL
CULLEN, DR
DOBSON, PRM
HORMONE RESEARCH, 1992, 37 (03) : 113 - 118
[43] EFFECT OF DOPAMINE AGONIST MEDICATION ON PROLACTIN PRODUCING PITUITARY-ADENOMAS - A MORPHOLOGICAL-STUDY INCLUDING IMMUNOCYTOCHEMISTRY, ELECTRON-MICROSCOPY AND INSITU HYBRIDIZATION
KOVACS, K
STEFANEANU, L
HORVATH, E
LLOYD, RV
LANCRANJAN, I
BUCHFELDER, M
FAHLBUSCH, R
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 418 (05) : 439 - 446
[44] VISUAL-LOSS IN PREGNANT-WOMEN WITH PITUITARY-ADENOMAS
KUPERSMITH, MJ
ROSENBERG, C
KLEINBERG, D
ANNALS OF INTERNAL MEDICINE, 1994, 121 (07) : 473 - 477
[45] Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: Evaluation with serial MR
Lundin, P
Engstrom, BE
Karlsson, FA
Burman, P
AMERICAN JOURNAL OF NEURORADIOLOGY, 1997, 18 (04) : 765 - 772
[46] Medical management of thyrotropin-secreting pituitary adenomas
Beck-Peccoz P.
Persani L.
Pituitary, 2002, 5 (2) : 83 - 88
[47] GH and Prolactin co-secreting Adenomas: It Is Time for a Definition
Wildemberg, Luiz Eduardo
Gadelha, Monica R.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (01) : e192 - e193
[48] HORMONAL CONTROL OF PITUITARY PROLACTIN-SECRETING TUMORS
Sarkar, Dipak K.
Hentges, Shane T.
De, Alok
Reddy, Raghaba H. R.
FRONTIERS IN BIOSCIENCE-LANDMARK, 1998, 3 : 934 - 943
[49] Pituitary apoplexy in an adolescent with prolactin-secreting adenoma
Pinto, G
Zerah, M
Trivin, C
Brauner, R
HORMONE RESEARCH, 1998, 50 (01) : 38 - 41
[50] Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas
Ilan Shimon
Ernesto Sosa
Victoria Mendoza
Yona Greenman
Amit Tirosh
Etual Espinosa
Vera Popovic
Andrea Glezer
Marcello D. Bronstein
Moises Mercado
Pituitary, 2016, 19 : 429 - 436

← 1 2 3 4 5 →